Janus Henderson Group
STOK icon

Janus Henderson Group’s Stoke Therapeutics STOK Stock Holding History

Janus Henderson Group’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.5M Buy
1,612,781
+161,848
+11% +$5.31M 0.03% 401
2025
Q4 		$46M Buy
1,450,933
+1,116,452
+334% +$33.6M 0.02% 431
2025
Q3 		$7.86M Buy
334,481
+315,581
+1,670% +$5.41M ﹤0.01% 799
2025
Q2 		$215K Hold
18,900
– – ﹤0.01% 2295
2025
Q1 		$136K Hold
18,900
– – ﹤0.01% 2431
2024
Q4 		$209K Hold
18,900
– – ﹤0.01% 2411
2024
Q3 		$232K Hold
18,900
– – ﹤0.01% 2376
2024
Q2 		$255K Buy
+18,900
New +$255K ﹤0.01% 2282
2020
Q2 		– Sell
-530,589
Closed -$12.2M – 1382
2020
Q1 		$12.2M Sell
530,589
-588,251
-53% -$14.5M 0.01% 783
2019
Q4 		$31.7M Sell
1,118,840
-25,735
-2% -$647K 0.02% 719
2019
Q3 		$23.9M Buy
1,144,575
+744,575
+186% +$20.8M 0.01% 786
2019
Q2 		$11.7M Buy
+400,000
New +$10.7M 0.01% 918

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Janus Henderson Group's STOK Position: Q1 2026 in Review

Janus Henderson Group increased its Stoke Therapeutics (STOK) stake by 11% in Q1 2026, buying an estimated $5.31M and bringing the position to 1,612,781 shares worth $52.5M. The position accounts for 0.03% of the portfolio, ranked #401.

Janus Henderson Group first reported a position in STOK in Q2 2019 and has held it in 12 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Janus Henderson Group held 1,612,781 shares of Stoke Therapeutics worth $52.5M as of Q1 2026.
  • Janus Henderson Group bought 161,848 Stoke Therapeutics shares in Q1 2026, an estimated $5.31M.
  • Stoke Therapeutics made up 0.03% of Janus Henderson Group's portfolio in Q1 2026, its #401 holding.
  • Janus Henderson Group first reported a position in Stoke Therapeutics in Q2 2019 and has held it in 12 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.